June 2019

In the next issue of Pharma Technology Focus, we take a look back at Scott Gottlieb’s tenure as FDA commissioner following his abrupt resignation announcement in March and explore the rise of Dutch tech start-up Pharmaoffer, which has created a digital platform for drugmakers to connect with qualified material suppliers.

Also, we examine whether there is still hope that the GDNF protein could form the basis for an effective Parkinson’s therapy after a major, multi-year trial of the GDNF protein produced disappointing results compared to placebo, and delve into the subject of cannabis related pharmaceuticals to unpick the myth from the real-deal drugs.

Plus, we find out if a protein produced in pregnancy could hold promise as a potential treatment for a range of age-related disorders such as Alzheimer’s and track the growth of antimicrobial resistance through sewage.


Editor | Eloise McLennan

Group Editor | Susanne Hauner

Commissioning Editor | Daniel Garrun

Writers | Abi Millar, Chris Lo, Allie Nawrat
Magazine Designer | Marzia Del Gaone

Graphic Designers | Paulius Zutautas, Kate Cuntapay, Anett Arc, Sara Basto, Ashley McPherson, Tyrrell Lowe, Noemi Balint
Lead Designer | John Hammond 
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453


Media Partnership Enquiries | Sophie Hoare

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Pharma Technology Focus is a product of Net Resources International. Copyright 2019 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.